Categories: CancerNews

From the Margins: Gilead’s Book Uniquely Captures What It’s Like To Be Marginalized by Disease

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

NORTHAMPTON, MA / ACCESSWIRE / January 30, 2024 / Gilead Sciences – The personal journeys of six people in the United Kingdom living with HIV, hepatitis C and cancer – and the challenges they face due to stigma and health inequities – come together in the form of a new, intentionally difficult-to-read book from Gilead. Entitled “From the Margins,” each person’s experience is deliberately written around the margins of the book in order to raise awareness of what it feels like to live on the periphery of society with a chronic or life-threatening disease.

“I had one foot in my cancer patient space and the other in my LGBTQ+ space,” reads an excerpt from one of the participants, named Stewart. “But there was no space where I could talk about both those things and bring them close to each other.”

Gilead teamed up with David Olusoga, a British historian and professor, to put the book together. “Throughout history and to this day, there are many people pushed to the margins of society where illness intertwines with social class, race, ethnicity, sexuality and poverty,” he says. “They shouldn’t have to take it upon themselves to overcome societies prejudices and inequalities.”

The book was published last September, and its unique format and important messages have earned significant media coverage and interest among the global patient and medical community.

The work is part of Gilead’s larger efforts to spotlight and address stigma, discrimination and other barriers to wellbeing and care; and ultimately, to improve health equity.

To read From the Margins, download a copy here.

View additional multimedia and more ESG storytelling from Gilead Sciences on 3blmedia.com.

Contact Info:
Spokesperson: Gilead Sciences
Website: https://www.3blmedia.com/profiles/gilead-sciences
Email: info@3blmedia.com

SOURCE: Gilead Sciences

View the original press release on accesswire.com

Staff

Recent Posts

Genflow Biosciences PLC Announces Update, Equity Issue and PDMR Notification

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION…

57 seconds ago

Neopharma Technologies Appoints Singapore Fintech Veteran and Serial Entrepreneur Mr. Joo Seng Wong as Board Advisor to Oversee Institutional Strategy and Global Execution

SINGAPORE, Oct. 8, 2025 /PRNewswire/ -- Neopharma Technologies Ltd ("Neopharma"), a digital health company pioneering…

3 hours ago

CERTIFY Health Releases New Insights Brief Revealing How Practices Achieve 400-600% ROI by Automating From the Point of Check-In

Data from 700+ healthcare leaders and 1,000+ practices shows measurable gains in revenue recovery, staff…

3 hours ago

EMA Wellness Bolsters Executive Leadership to Scale its Market Leading Clinical Trial Platform

New CMO, EVP Operations and SVP Clinical Solutions bring track records of scalable growth and…

3 hours ago

AYUMETRIX Launches Nova: Smart AI Companion for Wellness and Diagnostics

LAKE OSWEGO, Ore., Oct. 8, 2025 /PRNewswire/ -- AYUMETRIX, an early innovator for modern, at-home…

3 hours ago

eschbach Awarded Two Honors in the 2025 Pharmaceutical Technology Excellence Awards for Innovations in Pharmaceutical Manufacturing

BOSTON, Oct. 8, 2025 /PRNewswire/ -- eschbach, developer of Shiftconnector®, an intelligent operations platform for…

3 hours ago